Back to top

KRYS: Citigroup Adjusts Price Target, Maintains Neutral Rating | KRYS Stock News

KRYS: Citigroup Adjusts Price Target, Maintains Neutral Rating | KRYS Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Krystal Biotech, Inc. (KRYS)